Funding for Luxturna following MSAC recommendation
Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see ...
Tag: Luxturna
Sydney surgeon details first Luxturna gene therapy allowing patient to see stars
The vitreoretinal surgeon who performed Australia’s first Luxturna gene therapy has described the intricacy of the procedure, while hailing the ...
Siblings treated with Luxturna gene therapy in Australian first (video included)
Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular ...
Building Australia’s gene therapy capability
The rapidly evolving field of gene therapy offers a unique opportunity for Australian eye surgeons and scientists to join forces ...
Rewriting eye disease: Are we ready for gene therapies?
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment ...
Aussie IRD study taps into gene therapy perceptions
Researchers from the Centre for Eye Research Australia and University of Melbourne have developed a world-first survey to gather the ...
2020: a year like no other
Insight takes a look at the innovations, breakthroughs, setbacks, events and stories that shaped the Australian ophthalmic sector in 2020. ...
Race to identify inherited retinal disease patients for gene therapies
Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation ...
Reflections on a presidency
Two years has passed quickly and I will hand over to Associate Professor Nitin Verma on 10 October 2020. My ...
TGA approves Luxturna gene therapy
In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true ...